accountand Sanofi-Aventis SA (NYSE:SNY) have like Bristol-Myers. Nor is it likely Johnson & Johnson (NYSE:JNJ) or Abbott Laboratories (NYSE:ABT) would buy the company. Back to the drawing board, or perhaps the crystal ball. - Baz Hiralal...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Bristol-Myers sale? No, says analyst, reversing course
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account